Denali Therapeutics’ (DNLI) Outperform Rating Reiterated at William Blair
William Blair reaffirmed their outperform rating on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a report published on Wednesday,RTT News reports. Other equities research analysts also recently issued research reports about the company.
CVRx upgraded by William Blair to outperform
William Blair has upgraded CVRx (NASDAQ:CVRX) to outperform from market perform, citing utilization improvements and conservative guidance. The investment firm noted that after several "solid" quarters following a Q1 2024 miss and turnover in its sales force,
Sterling Infrastructure initiated with an Outperform at William Blair
William Blair initiated coverage of Sterling Infrastructure (STRL) with an Outperform rating.Stay Ahead of the Market:Discover outperforming
Affirm, SoFi Initiated At Outperform In Consumer Digital Financing
William Blair initiated coverage of Affirm stock and SoFi with outperform ratings viewing them as share gainers in the consumer financing market.
William Blair initiates coverage of digital finance stocks with an Outperform on SoFi, Affirm
SoFi Technologies (NASDAQ:SOFI) and Affirm Holdings (NASDAQ:AFRM) were rising after William Blair initiated coverage of the digital finance subsegment of fintech with an Outperform rating on the two stocks.
William Blair starts SoFi, Affirm with Outperform ratings
William Blair analyst Andrew Jeffrey initiated coverage of both SoFi Technologies (SOFI) and Affirm (AFRM) with Outperform ratings. The firm
William Blair Initiates Coverage of SoFi Technologies (SOFI) with Outperform Recommendation
Fintel reports that on January 15, 2025, William Blair initiated coverage of SoFi Technologies (NasdaqGS:SOFI) with a Outperform recommendation. Analyst Price Forecast Suggests 25.59% Downside As of December 23,
FY2024 EPS Estimates for Moderna Increased by William Blair
Equities researchers at William Blair raised their FY2024 EPS estimates for shares of Moderna in a research report issued to ...
Morningstar1d
William Blair International Growth I
William Blair International Growth Fund earns an Average Process Pillar rating. The most important driver of the rating is the stability of the management team. Specifically, the fund has not seen ...
bovnews16h
What’s Driving Tenaya Therapeutics Inc (TNYA) Stock’s -51.39% Plunge Over the Past Month?
Stock Trading Recap. On Friday, Tenaya Therapeutics Inc (TNYA) stock saw a modest uptick, ending the day at $1.4 which represents a slight increase ...
FierceBiotech3d
Neumora's dig into phase 3 depression data disappoints analysts
Neumora Therapeutics’ phase 3 fail was worse than analysts feared. | Neumora Therapeutics’ phase 3 fail was worse than ...
24/7 Wall St1d
SoFi Technologies (SOFI) Price Prediction and Forecast 2025-2030
For investors looking for opportunities in fintech, SoFi presents an interesting case. Here's where analysts think the stock ...
bovnews8h
Federal Signal Corp (FSS) Stock: Analyzing Its Quiet Power
On Friday, Federal Signal Corp (FSS) stock saw a decline, ending the day at $97.2 which represents a decrease of $-0.64 or -0.65% from the prior close of $97.84. The stock opened at $99.37 and touched ...
Karooooo’s Strong Q3 Performance and Optimistic FY 2025 Outlook Support Buy Rating
William Blair analyst Dylan Becker has maintained their bullish stance on KARO stock, giving a Buy rating on January 13.Stay Ahead of the ...
QSR magazine3d
Portillo’s, Like Usual, Charts a Fresh Path with Guest Loyalty
Portillo’s has never been one to follow the worn path in quick service. It hasn’t engaged in the “value wars” or materially ...